ArticlePediatric research2026
Impact of ABO blood group on NEC incidence and mortality in VLBW infants.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to investigate the relationship between ABO blood group and the incidence of necrotizing enterocolitis (NEC) or mortality in very low birth weight (VLBW) infants.
methodsA retrospective single-center cohort study was conducted on VLBW infants admitted to Shengjing Hospital of China Medical University from 2014 to 2023. Bell's staging system was used to define NEC severity, and deaths were recorded. Confirmed NEC with Bell's stage ≥2 and mortality were defined as primary outcomes and compared among the four ABO blood groups.
resultsThe primary composite outcome occurred in 14.7% (847/5774). Among the 5774 VLBW infants enrolled, the overall mortality was 11.0% (635/5774). Confirmed NEC (Bell's stage ≥2) occurred in 5.0% (288/5774) of the cohort, with NEC-related mortality of 21.2% (61/288). ABO blood groups were not associated with mortality and the incidence of NEC in VLBW infants. These findings remained consistent after adjusting for perinatal factors, maternal factors, and admission year.
conclusionThis study suggests no significant association between ABO blood group and NEC incidence, severity, or mortality in VLBW infants, contrasting with previous reports. Variations in study populations, definition of primary outcomes, statistical methods, and transfusion strategies may explain the differing findings. IMPACT: ABO blood groups have no influence on the incidence of confirmed NEC or mortality in VLBW infants. Variations in study populations, definitions of primary outcomes, and statistical methods may explain discrepancies between our findings and previous reports. Transfusion strategies may also confound the relationship between ABO blood group and NEC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.